Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SRK-181 |
Trade Name | |
Synonyms | SRK 181|SRK181 |
Drug Descriptions |
SRK-181 is TGFbeta1 (TGFB1) antibody, which potentially enhances anti-tumor immune response (PMID: 32213632). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C173598 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + SRK-181 | Pembrolizumab SRK-181 | 0 | 0 |
SRK-181 | SRK-181 | 0 | 1 |
SRK-181 + unspecified PD-1 antibody | SRK-181 unspecified PD-1 antibody | 0 | 1 |
SRK-181 + unspecified PD-L1 antibody | SRK-181 unspecified PD-L1 antibody | 0 | 1 |